Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care
Appropriations on Alzheimers screening and diagnosis
H.R.19, Lower Costs, More Cures Act of 2021
H.R. 5376, Build Back Better Act H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product Discussions regarding Medicaid 340B drug discount program
Reducing Out-of-Pocket Costs for Biosimilars in Medicare Part B
Support for H.R. 6179, Directing CMS to implement a shared savings model for biosimilars IP/Trade TRIPS Waiver
HCR - Health Issues PHA - Pharmacy MMM - Medicare/Medicaid TRD - Trade (domestic/foreign)
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
JONATHAN CAUSEY JOHN RAYMOND GIBSON CAROLINE TUCKER SUSAN KORNETSKY AMY DEMSKE AMY ABADIR JONATHAN CAUSEY AMY DEMSKE AMY ABADIR CAROLINE TUCKER TYLER HANSON (Office of Rep. McNerney 6/2015 - 2/2017) JONATHAN CAUSEY
Office of Rep. McNerney 6/2015 - 2/2017